Clinical trials
Completed Peri-Implantitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
180 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 9 |
| 2014 | 11 |
| 2015 | 6 |
| 2016 | 8 |
| 2017 | 14 |
| 2018 | 18 |
| 2019 | 11 |
| 2020 | 17 |
| 2021 | 13 |
| 2022 | 15 |
| 2023 | 18 |
| 2024 | 12 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 180 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain | 9 |
| Universitat Internacional de Catalunya | 9 |
| Aristotle University Of Thessaloniki | 5 |
| Universidad Complutense de Madrid | 5 |
| Università Vita-Salute San Raffaele | 4 |
| Abant Izzet Baysal University | 3 |
| Göteborg University | 3 |
| Necmettin Erbakan University | 3 |
| OraPharma | 3 |
| University Medical Center Groningen | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peri-Implantitis | 180 |
| Periodontal Diseases | 17 |
| Periodontitis | 16 |
| Alveolar Bone Loss | 7 |
| Mucositis | 7 |
| Inflammation | 5 |
| Bone Diseases, Metabolic | 4 |
| Infections | 3 |
| Dental Caries | 2 |
| Dental Plaque | 2 |
Trials
Showing 1 to 25 of 180. Each trial links to its page on Pharma Observatory.
80 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.